During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 0.38 million, with the beta value of the company hitting 0.80. At the end of the trading day, the stock’s price was $1.30, reflecting an intraday loss of -4.41% or -$0.06. The 52-week high for the QNCX share is $2.45, that puts it down -88.46 from that peak though still a striking 60.77% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $59.11M, and the average intraday trading volume over the past 10 days was 0.41 million shares, and the average trade volume was 326.74K shares over the past three months.

Quince Therapeutics Inc (NASDAQ:QNCX) trade information

Quince Therapeutics Inc (QNCX) registered a -4.41% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.41% in intraday trading to $1.30, hitting a weekly high. The stock’s 5-day price performance is 8.33%, and it has moved by 27.45% in 30 days. Based on these gigs, the overall price performance for the year is 83.10%. The short interest in Quince Therapeutics Inc (NASDAQ:QNCX) is 0.51 million shares and it means that shorts have 0.89 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.53%. While earnings are projected to return 25.95% in 2025, the next five years will return 25.46% per annum.

QNCX Dividends

Quince Therapeutics Inc is due to release its next quarterly earnings on 2025-May-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Quince Therapeutics Inc (NASDAQ:QNCX)’s Major holders

Quince Therapeutics Inc insiders own 12.71% of total outstanding shares while institutional holders control 22.25%, with the float percentage being 25.49%.